PAGE 2016 - Lisboa, Portugal

Wojciech Krzyzanski, PhD, MA. Associate Professor at Department of Pharmaceutical Sciences, University at Buffalo. Holds PhD in applied mathematics and MA in pharmacology. Research focus on pharmacokinetics and pharmacodynamics of hematopoietic growth factors and pharmacometrics.

Gilbert Koch, PhD. Gilbert Koch holds a PhD in applied mathematics. He worked as Postdoctoral Associate at the Department of Pharmaceutical Sciences, University at Buffalo and recently joined the Pediatric Pharmacology Group at the University Children´s Hospital in Basel as Senior Research Fellow. His research focus is on delay/lifespan modeling, anti-cancer effects in combination therapy, modeling in pediatric drug development and rare diseases, and target mediated drug disposition with drug-drug interaction.

Johannes Schropp, PhD. Professor at Department of Mathematics and Statistics, University of Konstanz. Research focus on PK/PD modeling and numerics of dynamical systems.

Matthias Machacek, PhD. Matthias Machacek studied mechanical engineering and obtained his PhD from ETH Zurich for his research on fluid dynamics and computer vision. During his postdoc at Scripps he applied computer vision to monitor molecules inside live cells at nanometer scale. His research was published in both Nature and Science. After, Matthias established the Medical Engineering Group at Novartis, dedicated to the systems pharmacology support for the preclinical and translational development of biotherapeutics.Today, Machacek applies systems pharmacology

for the development of biologics and cell based therapeutics. He is Managing Director of LYO-X and contributes to compound design, format selection, candidate selection, PK/PD and toxicology study design, first in human dose selection, optimal dose-regimen finding and pediatric development. He also works with Lixoft as a pharmacometrics expert developing and promoting the Monolix software suite.